Process View
28 genes annotated in human
DOID:9455
A lysosomal storage disease that involves the accumulation of harmful amounts of lipids (fats) in some of the body's cells and tissues.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "lipid storage disease"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CTSA | cathepsin A | 1.000 | ||
| LAMP1 | lysosomal-associated membrane protein 1 | 1.000 | ||
| GRN | granulin | 0.998 | ||
| PSAP | prosaposin | 0.994 | ||
| NEU1 | sialidase 1 (lysosomal sialidase) | 0.991 | ||
| TPP1 | tripeptidyl peptidase I | 0.968 | ||
| CTSD | cathepsin D | 0.961 | ||
| GNS | glucosamine (N-acetyl)-6-sulfatase | 0.941 | ||
| CTSB | cathepsin B | 0.838 | ||
| HEXB | hexosaminidase B (beta polypeptide) | 0.818 | ||
| GM2A | GM2 ganglioside activator | 0.723 | ||
| LAMP2 | lysosomal-associated membrane protein 2 | 0.606 | ||
| ATP6AP1 | ATPase, H+ transporting, lysosomal accessory protein 1 | 0.575 | ||
| NPC2 | Niemann-Pick disease, type C2 | 0.430 | ||
| PLD3 | phospholipase D family, member 3 | 0.429 | ||
| GAA | glucosidase, alpha; acid | 0.416 | ||
| GLB1 | galactosidase, beta 1 | 0.413 | ||
| MAN2B1 | mannosidase, alpha, class 2B, member 1 | 0.376 | ||
| OS9 | osteosarcoma amplified 9, endoplasmic reticulum lectin | 0.318 | ||
| APLP2 | amyloid beta (A4) precursor-like protein 2 | 0.211 | ||
| A2M | alpha-2-macroglobulin | 0.194 | ||
| CST3 | cystatin C | 0.164 | ||
| MFSD1 | major facilitator superfamily domain containing 1 | 0.150 | ||
| APOC1 | apolipoprotein C-I | 0.144 | ||
| C1orf85 | chromosome 1 open reading frame 85 | 0.144 | ||
| ANXA4 | annexin A4 | 0.127 | ||
| GABARAP | GABA(A) receptor-associated protein | 0.126 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.108 | ||
| HLA-C | major histocompatibility complex, class I, C | 0.100 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.098 | ||
| FCGRT | Fc fragment of IgG, receptor, transporter, alpha | 0.096 | ||
| HLA-G | major histocompatibility complex, class I, G | 0.093 | ||
| FUCA1 | fucosidase, alpha-L- 1, tissue | 0.088 | ||
| GNPTG | N-acetylglucosamine-1-phosphate transferase, gamma subunit | 0.088 | ||
| HEXA | hexosaminidase A (alpha polypeptide) | 0.082 | ||
| USP22 | ubiquitin specific peptidase 22 | 0.076 | ||
| MANBA | mannosidase, beta A, lysosomal | 0.074 | ||
| PRCP | prolylcarboxypeptidase (angiotensinase C) | 0.073 | ||
| CTSL1 | cathepsin L1 | 0.069 | ||
| FTL | ferritin, light polypeptide | 0.066 | ||
| NUCB1 | nucleobindin 1 | 0.062 | ||
| ATP6V0D1 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 | 0.059 | ||
| CSTB | cystatin B (stefin B) | 0.054 | ||
| SCPEP1 | serine carboxypeptidase 1 | 0.052 | ||
| PBXIP1 | pre-B-cell leukemia homeobox interacting protein 1 | 0.050 | ||
| CTSH | cathepsin H | 0.048 | ||
| NCSTN | nicastrin | 0.044 | ||
| RNF13 | ring finger protein 13 | 0.042 | ||
| SH3BGRL | SH3 domain binding glutamic acid-rich protein like | 0.038 | ||
| MR1 | major histocompatibility complex, class I-related | 0.038 | ||
| DNASE2 | deoxyribonuclease II, lysosomal | 0.038 | ||
| HP | haptoglobin | 0.037 | ||
| NAGPA | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | 0.037 | ||
| NAGA | N-acetylgalactosaminidase, alpha- | 0.036 | ||
| ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | 0.035 | ||
| FTH1 | ferritin, heavy polypeptide 1 | 0.034 | ||
| CREG1 | cellular repressor of E1A-stimulated genes 1 | 0.034 | ||
| TSC22D1 | TSC22 domain family, member 1 | 0.034 | ||
| ATP6V0C | ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c | 0.033 | ||
| CD63 | CD63 molecule | 0.033 | ||
| NAGK | N-acetylglucosamine kinase | 0.032 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.031 | ||
| NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 0.030 | ||
| PGCP | plasma glutamate carboxypeptidase | 0.028 | ||
| GUSB | glucuronidase, beta | 0.027 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.027 | ||
| P2RX4 | purinergic receptor P2X, ligand-gated ion channel, 4 | 0.026 | ||
| PTTG1IP | pituitary tumor-transforming 1 interacting protein | 0.026 | ||
| ATP6V0E1 | ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 | 0.025 | ||
| EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) | 0.025 | ||
| FBXO6 | F-box protein 6 | 0.025 | ||
| MVP | major vault protein | 0.024 | ||
| SGSH | N-sulfoglucosamine sulfohydrolase | 0.023 | ||
| GBA | glucosidase, beta, acid | 0.023 | ||
| IFI30 | interferon, gamma-inducible protein 30 | 0.023 | ||
| LTA4H | leukotriene A4 hydrolase | 0.023 | ||
| LRP10 | low density lipoprotein receptor-related protein 10 | 0.022 | ||
| PEPD | peptidase D | 0.022 | ||
| PLTP | phospholipid transfer protein | 0.022 | ||
| ZBED1 | zinc finger, BED-type containing 1 | 0.021 | ||
| PPT1 | palmitoyl-protein thioesterase 1 | 0.021 | ||
| GPNMB | glycoprotein (transmembrane) nmb | 0.021 | ||
| MAN2B2 | mannosidase, alpha, class 2B, member 2 | 0.020 | ||
| MCOLN1 | mucolipin 1 | 0.018 | ||
| TMEM127 | transmembrane protein 127 | 0.018 | ||
| LIPA | lipase A, lysosomal acid, cholesterol esterase | 0.018 | ||
| BRI3 | brain protein I3 | 0.017 | ||
| EDEM2 | ER degradation enhancer, mannosidase alpha-like 2 | 0.017 | ||
| TOM1 | target of myb1 (chicken) | 0.017 | ||
| GNPDA1 | glucosamine-6-phosphate deaminase 1 | 0.016 | ||
| CTNS | cystinosis, nephropathic | 0.016 | ||
| LGMN | legumain | 0.016 | ||
| SUMF1 | sulfatase modifying factor 1 | 0.016 | ||
| SLC25A11 | solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 | 0.015 | ||
| SLC22A18 | solute carrier family 22, member 18 | 0.015 | ||
| GANAB | glucosidase, alpha; neutral AB | 0.015 | ||
| GPR137B | G protein-coupled receptor 137B | 0.015 | ||
| CD68 | CD68 molecule | 0.015 | ||
| HMOX1 | heme oxygenase (decycling) 1 | 0.014 | ||
| CLCN7 | chloride channel 7 | 0.014 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.014 | ||
| LGALS3BP | lectin, galactoside-binding, soluble, 3 binding protein | 0.014 | ||
| SLC38A7 | solute carrier family 38, member 7 | 0.013 | ||
| ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | 0.013 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.013 | ||
| LRPAP1 | low density lipoprotein receptor-related protein associated protein 1 | 0.013 | ||
| SIGMAR1 | sigma non-opioid intracellular receptor 1 | 0.013 | ||
| RPS6KA1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 | 0.013 | ||
| RPN2 | ribophorin II | 0.013 | ||
| TMEM179B | transmembrane protein 179B | 0.013 | ||
| ARSA | arylsulfatase A | 0.012 | ||
| EXT2 | exostosin 2 | 0.012 | ||
| UNC45A | unc-45 homolog A (C. elegans) | 0.012 | ||
| SLC17A5 | solute carrier family 17 (anion/sugar transporter), member 5 | 0.012 | ||
| SIDT2 | SID1 transmembrane family, member 2 | 0.012 | ||
| RNASET2 | ribonuclease T2 | 0.011 | ||
| ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 | 0.011 | ||
| ACP5 | acid phosphatase 5, tartrate resistant | 0.011 | ||
| TMBIM4 | transmembrane BAX inhibitor motif containing 4 | 0.011 | ||
| TMEM9B | TMEM9 domain family, member B | 0.010 | ||
| CTSO | cathepsin O | 0.010 | ||
| GALC | galactosylceramidase | 0.010 | ||
| CLN3 | ceroid-lipofuscinosis, neuronal 3 | 0.008 | ||
| GLA | galactosidase, alpha | 0.007 | ||
| CYP27A1 | cytochrome P450, family 27, subfamily A, polypeptide 1 | 0.006 | ||
| ABHD5 | abhydrolase domain containing 5 | 0.005 | ||
| CTSF | cathepsin F | 0.004 | ||
| NPC1 | Niemann-Pick disease, type C1 | 0.004 | ||
| CLN8 | ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) | 0.004 | ||
| CLN6 | ceroid-lipofuscinosis, neuronal 6, late infantile, variant | 0.003 | ||
| DNAJC5 | DnaJ (Hsp40) homolog, subfamily C, member 5 | 0.003 | ||
| APOE | apolipoprotein E | 0.003 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.002 | ||
| CLN5 | ceroid-lipofuscinosis, neuronal 5 | 0.002 | ||
| MFSD8 | major facilitator superfamily domain containing 8 | 0.001 |